13F HOLDINGS REPORT
Casdin Capital, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0000919574-25-007006
Total Value
$1.20B
Positions
32
Other Managers
0
Confidential Omitted
No
Holdings (32)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GENEDX HOLDINGS CORP | WGSWW | 3,007,164 | $324.0M | 27.01% |
| 2 | BIOLIFE SOLUTIONS INC | BLFS | 6,707,165 | $171.1M | 14.27% |
| 3 | REVOLUTION MEDICINES INC | RVMDW | 2,647,333 | $123.6M | 10.31% |
| 4 | STANDARD BIOTOOLS INC | LAB | 77,558,856 | $100.8M | 8.41% |
| 5 | AVIDITY BIOSCIENCES INC | 05370A108 | 1,780,000 | $77.6M | 6.47% |
| 6 | RELAY THERAPEUTICS INC | RLAY | 11,341,381 | $59.2M | 4.94% |
| 7 | ILLUMINA INC | ILMN | 525,000 | $49.9M | 4.16% |
| 8 | STRUCTURE THERAPEUTICS INC | GPCR | 1,555,000 | $43.5M | 3.63% |
| 9 | BEAM THERAPEUTICS INC | BEAM | 1,600,000 | $38.8M | 3.24% |
| 10 | ALNYLAM PHARMACEUTICALS INC | ALNY | 55,000 | $25.1M | 2.09% |
| 11 | TEMPUS AI INC | TEM | 294,127 | $23.7M | 1.98% |
| 12 | NEUROGENE INC | NGNE | 1,295,361 | $22.4M | 1.87% |
| 13 | MAZE THERAPEUTICS INC | MAZE | 758,857 | $19.7M | 1.64% |
| 14 | PRIME MEDICINE INC | PRME | 3,167,175 | $17.5M | 1.46% |
| 15 | ARS PHARMACEUTICALS INC | SPRY | 1,600,000 | $16.1M | 1.34% |
| 16 | HIMS & HERS HEALTH INC | HIMS | 230,000 | $13.0M | 1.09% |
| 17 | DENALI THERAPEUTICS INC | DNLI | 890,000 | $12.9M | 1.08% |
| 18 | SEPTERNA INC | SEPN | 553,268 | $10.4M | 0.87% |
| 19 | VERACYTE INC | VCYT | 276,308 | $9.5M | 0.79% |
| 20 | UNITEDHEALTH GROUP INC | UNH | 25,000 | $8.6M | 0.72% |
| 21 | INCYTE CORP | INCY | 100,000 | $8.5M | 0.71% |
| 22 | GUARDANT HEALTH INC | GH | 100,000 | $6.2M | 0.52% |
| 23 | EXACT SCIENCES CORP | 30063P105 | 90,000 | $4.9M | 0.41% |
| 24 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 282,312 | $3.3M | 0.27% |
| 25 | ABSCI CORPORATION | ABSI | 973,260 | $3.0M | 0.25% |
| 26 | CONTINEUM THERAPEUTICS INC | CTNM | 148,333 | $1.7M | 0.15% |
| 27 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 723,767 | $926,422 | 0.08% |
| 28 | RECURSION PHARMACEUTICALS IN | RXRX | 165,323 | $806,776 | 0.07% |
| 29 | MONTE ROSA THERAPEUTICS INC | GLUE | 86,014 | $637,364 | 0.05% |
| 30 | CENTURY THERAPEUTICS INC | IPSC | 1,228,190 | $611,639 | 0.05% |
| 31 | TENAYA THERAPEUTICS INC | TNYA | 361,969 | $586,390 | 0.05% |
| 32 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 36,493 | $532,068 | 0.04% |